Specific IDH1 and IDH2 mutations are characteristic of distinct subtypes, including low‐grade gliomas, secondary GBMs, chondrosarcomas, intrahepatic cholangiocarcinomas, and certain hematologic cancers.56 This evidence concerns the gene IDH2 and glioma.